The DOI matches its Crossref record.
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- Ambinder, 1990, Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens, Mol. Cell. Probes, 4, 397, 10.1016/0890-8508(90)90030-4 · DOI
- Baer, 1984, DNA sequence and expression of the B95-8 Epstein-Barr virus genome, Nature, 310, 207, 10.1038/310207a0 · DOI · Paper page
- Freedman, 1987, B7, a B-cell-restricted antigen that identifies preactivated B cells, J. Immunol., 139, 3260, 10.4049/jimmunol.139.10.3260 · DOI
- Gregory, 1987, Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype, J. Immunol., 139, 313, 10.4049/jimmunol.139.1.313 · doi:10.4049/jimmunol.139.1.313
- Hurley, 1988, B cell activation and the establishment of Epstein-Barr virus latency, J. Exp. Med., 168, 2059, 10.1084/jem.168.6.2059 · doi:10.1084/jem.168.6.2059
- Jones, 1988, T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections, N. Engl. J. Med., 318, 733, 10.1056/NEJM198803243181203 · doi:10.1056/nejm198803243181203
- Khanna, 1992, Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development, J. Exp. Med., 176, 169, 10.1084/jem.176.1.169 · DOI · Paper page
- Klein, 1989, Viral latency and transformation: the strategy of Epstein-Barr virus, Cell, 58, 5, 10.1016/0092-8674(89)90394-2 · DOI · Paper page
- Klein, 1994, Epstein-Barr virus strategy in normal and neoplastic B cells, Cell, 77, 791, 10.1016/0092-8674(94)90125-2 · DOI
- Klein, 1985, Evolution of tumours and the impact of molecular oncology, Nature, 315, 190, 10.1038/315190a0 · DOI · Paper page
- Lam, 1991, Circulating Epstein-Barr virus-carrying B cells in acute malaria, Lancet, 337, 876, 10.1016/0140-6736(91)90203-2 · DOI
- Lewin, 1987, Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth, Int. J. Cancer, 39, 472, 10.1002/ijc.2910390411 · doi:10.1002/ijc.2910390411
- Rickinson, 1985, The Epstein-Barr virus as a model of virus-host interactions, Br. Med. Bull., 41, 75, 10.1093/oxfordjournals.bmb.a072030 · doi:10.1093/oxfordjournals.bmb.a072030
- Rowe, 1987, Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells, EMBO J., 6, 2743, 10.1002/j.1460-2075.1987.tb02568.x · DOI · Paper page
- Saito, 1989, Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome, J. Exp. Med., 169, 2191, 10.1084/jem.169.6.2191 · DOI
- Schlossman, 1994, CD antigens, 1993, Immunol. Today, 15, 98, 10.1016/0167-5699(94)90149-X · DOI
- Sixbey, 1983, Replication of Epstein-Barr virus in human epithelial cells infected in vitro, Nature, 306, 480, 10.1038/306480a0 · doi:10.1038/306480a0
- Sugden, 1979, Epstein-Barr virus DNA is amplified in transformed lymphocytes, J. Virol., 31, 590, 10.1128/JVI.31.3.590-595.1979 · DOI
- Telenti, 1990, Detection of Epstein-Barr virus by polymerase chain reaction, J. Clin. Microbiol., 28, 2187, 10.1128/JCM.28.10.2187-2190.1990 · DOI
- Tew, 1980, The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells, Immunol. Rev., 53, 175, 10.1111/j.1600-065X.1980.tb01044.x · DOI · Paper page
- Thomas, 1990, Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals, Transplantation, 49, 944, 10.1097/00007890-199005000-00022 · doi:10.1097/00007890-199005000-00022
- Thorley-Lawson, 1989, Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases, Biochim. Biophys. Acta, 948, 263
- Wagner, 1992, Detection and quantitation of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction, J. Clin. Microbiol., 30, 2826, 10.1128/JCM.30.11.2826-2829.1992 · DOI
- Wyatt, 1992, BCL2 oncogene translocation is mediated by a χ-like consensus, J. Exp. Med., 175, 1575, 10.1084/jem.175.6.1575 · DOI
- Yao, 1985, In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients, Int. J. Cancer, 35, 43, 10.1002/ijc.2910350108 · doi:10.1002/ijc.2910350108
- Yao, 1989, Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers, Int. J. Cancer, 43, 67, 10.1002/ijc.2910430115 · DOI
- Yao, 1991, Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities, Int. J. Cancer, 48, 253, 10.1002/ijc.2910480217 · doi:10.1002/ijc.2910480217
- York, 1994, A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes, Cell, 77, 525, 10.1016/0092-8674(94)90215-1 · DOI · Paper page
Cited by
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
Plottel, C. S., & Blaser, M. J. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.003 · Cited by 743
The mitochondrial pathways of apoptosis
Estaquier, J., Vallette, F., Vayssiere, J.-L., & Mignotte, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_7 · Cited by 637
p53 and E2f: partners in life and death
Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498
BID regulation by p53 contributes to chemosensitivity
Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsmeyer, S. J., & El-Deiry, W. S. (2002) · Nature Cell Biology · doi:10.1038/ncb866 · Cited by 420
Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3077 · Cited by 355
ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis
Pabla, N., Huang, S., Mi, Q.-S., Daniel, R., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707568200 · Cited by 309
Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM.
Enoch, T., & Norbury, C. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89093-3 · Cited by 261
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
Gressner, O., Schilling, T., Lorenz, K., Schulze Schleithoff, E., Koch, A., Schulze‐Bergkamen, H., Maria Lena, A., Candi, E., Terrinoni, A., Valeria Catani, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600708 · Cited by 255
Li, P.-X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., & Klamut, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909580199 · Cited by 254
Yamaguchi, A., Tamatani, M., Matsuzaki, H., Namikawa, K., Kiyama, H., Vitek, M. P., Mitsuda, N., & Tohyama, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008552200 · Cited by 242
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224
A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains.
Zapata, J. M., Pawlowski, K., Haas, E., Ware, C. F., Godzik, A., & Reed, J. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100354200 · Cited by 228
Cuddihy, A. R., Hoi-Tao Wong, A., Wai Ning Tam, N., Li, S., & Koromilas, A. E. (1999) · Oncogene · doi:10.1038/sj.onc.1202620 · Cited by 203
Regulation of AIF expression by p53
Stambolsky, P., Weisz, L., Shats, I., Klein, Y., Goldfinger, N., Oren, M., & Rotter, V (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401965 · Cited by 194
Stad, R., Ramos, Y. F. M., Little, N., Grivell, S., Attema, J., van der Eb, A. J., & Jochemsen, A. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003496200 · Cited by 145
Calcium signaling alterations, oxidative stress, and autophagy in aging
Ureshino, R. P., Rocha, K. K., Lopes, G. S., Bincoletto, C., & Smaili, S. S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5777 · Cited by 143
p53 Induces Myocyte Apoptosis via the Activation of the Renin–Angiotensin System
Pierzchalski, P., Reiss, K., Cheng, W., Cirielli, C., Kajstura, J., Nitahara, J. A., Rizk, M., Capogrossi, M. C., & Anversa, P. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3604 · Cited by 135
Munsch, D., Watanabe-Fukunaga, R., Bourdon, J.-C., Nagata, S., May, E., Yonish-Rouach, E., & Reisdorf, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3867 · Cited by 131
The Biological Functions and Signaling Mechanisms of the p75 Neurotrophin Receptor
Kraemer, B. R., Yoon, S. O., & Carter, B. D. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_6 · Cited by 125
Proteolytic Cleavage of the mdm2 Oncoprotein during Apoptosis
Chen, L., Marechal, V., Moreau, J., Levine, A. J., & Chen, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22966 · Cited by 121
Krones-Herzig, A., Adamson, E., & Mercola, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628034100 · Cited by 118
Liu, G., & Chen, X. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1398-1413.2006 · Cited by 104
Masuya, D., Huang, C., Liu, D., Nakashima, T., Yokomise, H., Ueno, M., Nakashima, N., & Sumitomo, S. (2006) · The Journal of Pathology · doi:10.1002/path.1931 · Cited by 103
Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation
ZHAN, Q., FAN, S., SMITH, M. L., BAE, I., YU, K., ALAMO, I., O'CONNOR, P. M., & FORNACE, A. J. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.805 · Cited by 97
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Hong, W., Kim, A. Y., Ky, S., Rakowski, C., Seo, S.-B., Chakravarti, D., Atchison, M., & Blobel, G. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3729-3743.2002 · Cited by 74
Influence of apoptosis on neurological outcome following traumatic cerebral contusion
Nathoo, N., Narotam, P. K., Agrawal, D. K., Connolly, C. A., van Dellen, J. R., Barnett, G. H., & Chetty, R. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.101.2.0233 · Cited by 62
Sax, J. K., & El-Deiry, W. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303191200 · Cited by 60
Genotoxic stress/p53-induced DNAJB9 inhibits the pro-apoptotic function of p53
Lee, H. J., Kim, J. M., Kim, K. H., Heo, J. I., Kwak, S. J., & Han, J. A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.116 · Cited by 60
Vogt, M., Butz, K., Dymalla, S., Semzow, J., & Hoppe-Seyler, F. (2006) · Oncogene · doi:10.1038/sj.onc.1209429 · Cited by 54
Gama, V, Gomez, J. A., Mayo, L. D., Jackson, M. W., Danielpour, D., Song, K., Haas, A. L., Laughlin, M. J., & Matsuyama, S. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.6 · Cited by 46
Mantovani, F., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202688 · Cited by 46
miR-23a binds to p53 and enhances its association with miR-128 promoter
Li, J., Aung, L. H. H., Long, B., Qin, D., An, S., & Li, P. (2015) · Scientific Reports · doi:10.1038/srep16422 · Cited by 45
Full-length hdmX transcripts decrease following genotoxic stress
Markey, M., & Berberich, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.266 · Cited by 38
p53 directly regulates the glycosidase FUCA1 to promote chemotherapy-induced cell death
Baudot, A. D., Crighton, D., O'Prey, J., Somers, J., Sierra Gonzalez, P., & Ryan, K. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191714 · Cited by 31
Matarrese, P., Tieri, P., Anticoli, S., Ascione, B., Conte, M., Franceschi, C., Malorni, W., Salvioli, S., & Ruggieri, A. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1888-3 · Cited by 27
(1998) · doi:10.1002/(sici)1098-2744(199806)22:2<128::aid-mc8>3.0.co;2-i
(2000) · doi:10.1002/(sici)1098-2264(200004)27:4
Metadata
- Authors
- Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1995-02
- Volume
- 80
- Issue
- 4
- Pages
- 593-601
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1983386156
- Cited by
- 1,593
- References
- 0
- FWCI
- 44.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6741 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.